Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen
Open Access
- 1 November 2001
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 15 (13) , 2365-2376
- https://doi.org/10.1096/fj.01-0201com
Abstract
Proteolytic cleavage of single-chain, high molecular weight kininogen (HK) by kallikrein releases the short-lived vasodilator bradykinin and leaves behind a two-chain, high molecular weight kininogen (HKa) reported to bind to the β2-integrin Mac-1 (CR3, CD11b/CD18, αMβ2) on neutrophils and exert antiad-hesive properties by binding to the urokinase receptor (uPAR) and vitronectin. We define the molecular mechanisms for the antiadhesive effects of HK related to disruption of β2-integrin-mediated cellular interactions in vitro and in vivo. In a purified system, HK and HKa inhibited the binding of soluble fibrinogen and ICAM-1 to immobilized Mac-1, but not the binding of ICAM-1 to immobilized LFA-1 (CD11a/CD18, αLβ2). This inhibitory effect could be attributed to HK domain 5 and to a lesser degree to HK domain 3, consistent with the requirement of both domains for binding to Mac-1. Accordingly, HK, HKa, and domain 5 inhibited the adhesion of Mac-1 but not LFA-1-transfected K562 human erythroleukemic cells to ICAM-1. Moreover, adhesion of human monocytic cells to fibrinogen and to human endothelial cells was blocked by HK, HKa, and domain 5. By using peptides derived from HK domain 5, the sequences including amino acids H475-G497 (and to a lesser extent, G440-H455) were identified as responsible for the antiadhesive effect, which was independent of uPAR. Finally, administration of domain 5 into mice, followed by induction of thioglycol-late-provoked peritonitis, decreased the recruitment of neutrophils by ~70% in this model of acute inflammation. Taken together, HKa (and particularly domain 5) specifically interacts with Mac-1 but not with LFA-1, thereby blocking Mac-1-dependent leukocyte adhesion to fibrinogen and endothelial cells in vitro and in vivo and serving as a novel endogenous regulator of leuko-cyte recruitment into the inflamed tissue.—Chavakis, T., Kanse, S. M., Pixley, R. A., May, A. E., Isordia-Salas, I., Colman, R. W., Preissner, K. T. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J. 15, 2365–2376 (2001)Keywords
This publication has 42 references indexed in Scilit:
- Two‐chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5The FASEB Journal, 2000
- Neutrophil Emigration in the Skin, Lungs, and Peritoneum: Different Requirements for CD11/CD18 Revealed by CD18-deficient MiceThe Journal of Experimental Medicine, 1997
- Sequential observation of micrometastasis formation by bacterial lacZ gene-tagged Lewis lung carcinoma cellsCancer Letters, 1997
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Inhibition of cell adhesion by high molecular weight kininogen.The Journal of cell biology, 1992
- The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc‐dependent binding to an anionic surfaceProtein Science, 1992
- High molecular weight kininogen inhibits fibrinogen binding to cytoadhesins of neutrophils and platelets.The Journal of cell biology, 1989
- Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.Journal of Clinical Investigation, 1989
- High molecular weight kininogen is an inhibitor of platelet calpain.Journal of Clinical Investigation, 1986
- FITZGERALD FACTOR: A HITHERTO UNRECOGNISED COAGULATION FACTORThe Lancet, 1975